Yi‐Peng Fu

1.1k total citations
32 papers, 816 citations indexed

About

Yi‐Peng Fu is a scholar working on Oncology, Cancer Research and Hepatology. According to data from OpenAlex, Yi‐Peng Fu has authored 32 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 14 papers in Cancer Research and 12 papers in Hepatology. Recurrent topics in Yi‐Peng Fu's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cancer, Lipids, and Metabolism (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Yi‐Peng Fu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cancer, Lipids, and Metabolism (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Yi‐Peng Fu collaborates with scholars based in China, Ethiopia and United States. Yi‐Peng Fu's co-authors include Yong Yi, Jian Zhou, Shuang–Jian Qiu, Jia Fan, Xiaochun Ni, Jinlong Huang, Wei Gan, Chuyu Jing, Xiaoyan Cai and Jiaxing Wang and has published in prestigious journals such as Oncogene, British Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Yi‐Peng Fu

31 papers receiving 810 citations

Peers

Countries citing papers authored by Yi‐Peng Fu

Since Specialization

Citations

This map shows the geographic impact of Yi‐Peng Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Peng Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Peng Fu more than expected).

Fields of papers citing papers by Yi‐Peng Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Peng Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Peng Fu. The network helps show where Yi‐Peng Fu may publish in the future.

Co-authorship network of co-authors of Yi‐Peng Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Peng Fu. A scholar is included among the top collaborators of Yi‐Peng Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Peng Fu. Yi‐Peng Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of IRE1α/XBP1 axis alleviates LPS-induced acute lung injury by suppressing TXNIP/NLRP3 inflammasome activation and ERK/p65 signaling pathway 2024 ·Respiratory Research ·Sijiao Wang, (unknown), Yi‐Peng Fu, (unknown), (unknown), Hanhan Liu, Lei Zhu	0
2	Identification and validation of ferroptosis-related genes in lipopolysaccharide-induced acute lung injury 2023 ·Cellular Signalling ·(unknown), (unknown), Fan Xu, (unknown), (unknown), Lijuan Hu, Yi‐Peng Fu, Lei Zhu	13
3	A tumor microenvironment-related risk model for predicting the prognosis and tumor immunity of breast cancer patients 2022 ·Frontiers in Immunology ·(unknown), Yi‐Peng Fu, (unknown), (unknown)	4
4	Predictive nomogram based on serum tumor markers and clinicopathological features for stratifying lymph node metastasis in breast cancer 2022 ·BMC Cancer ·(unknown), (unknown), Hongwei Zhang, Yi‐Peng Fu	10
5	Tumor infiltrating neutrophil might play a major role in predicting the clinical outcome of breast cancer patients treated with neoadjuvant chemotherapy 2021 ·BMC Cancer ·(unknown), (unknown), Shihong Ma, Yi‐Peng Fu, Hongwei Zhang	9
6	Hepatic stellate cells promote intrahepatic cholangiocarcinoma progression via NR4A2/osteopontin/Wnt signaling axis 2021 ·Oncogene ·Chuyu Jing, Yi‐Peng Fu, Cheng Zhou, Meixia Zhang, Yong Yi, Jinlong Huang, Wei Gan, Juan Zhang, Su-Su Zheng, Boheng Zhang, Shuang–Jian Qiu	17
7	An Innovative Immune Score‐Based Prognostic Nomogram for Patients with Cervical Cancer 2020 ·BioMed Research International ·(unknown), Yi‐Peng Fu, Meng Zhang, Chong Lu, Yumeng Wang, Jing Peng, Guiling Li	3
8	Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer 2020 ·Journal for ImmunoTherapy of Cancer ·Fang Bai, Peng Zhang, Yi‐Peng Fu, Hongliang Chen, Mingdi Zhang, Qianru Huang, Dan Li, Bin Li, Kejin Wu	82
9	Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-RORα-Wnt/β-Catenin axis 2020 ·Cancer Letters ·Jinlong Huang, Yi‐Peng Fu, Wei Gan, Gao Liu, Pei‐Yun Zhou, Cheng Zhou, Bao‐Ye Sun, Ruo‐Yu Guan, Jian Zhou, Jia Fan, Yong Yi, Shuang‐Jian Qiu	53
10	<p>Role of Lipids and Apolipoproteins in Predicting the Prognosis of Hepatocellular Carcinoma After Resection</p> 2020 ·OncoTargets and Therapy ·Xiaochun Ni, Yong Yi, Yi‐Peng Fu, Xiaoyan Cai, Gao Liu, Jinlong Huang, Wei Gan, Jie Xu, Shuang‐Jian Qiu	14
11	HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1 2019 ·Journal for ImmunoTherapy of Cancer ·Chuyu Jing, Yi‐Peng Fu, Yong Yi, Meixia Zhang, Su-Su Zheng, Jinlong Huang, Wei Gan, Xin Xu, Jiajia Lin, Juan Zhang, Shuang–Jian Qiu, Boheng Zhang	91
12	Inflammation–nutrition score predicts prognosis of patients with resectable hepatocellular carcinoma 2019 ·International Journal of Clinical Oncology ·Xiaochun Ni, Jie Xu, Yong Yi, Yi‐Peng Fu, Xiaoyan Cai, Gao Liu, Jinlong Huang, Wei Gan, Shuang–Jian Qiu	7
13	Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection 2017 ·Medicine ·Chuyu Jing, Yi‐Peng Fu, Su-Su Zheng, (unknown), (unknown), Jinlong Huang, (unknown), Jiajia Lin, Jian Zhou, Jia Fan, Zhenggang Ren, Shuang–Jian Qiu, Boheng Zhang	6
14	Serum gamma-glutamyl transferase levels affect the prognosis of patients with intrahepatic cholangiocarcinoma who receive postoperative adjuvant transcatheter arterial chemoembolization: A propensity score matching study 2016 ·International Journal of Surgery ·(unknown), Shuang Liu, Yong Yi, Xiaochun Ni, Jiaxing Wang, Jinlong Huang, Yi‐Peng Fu, Yabing Cao, Jian Zhou, Jia Fan, Shuang–Jian Qiu	14
15	Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection 2016 ·British Journal of Cancer ·Yi‐Peng Fu, Yong Yi, Xiaoyan Cai, Jian Sun, Xiaochun Ni, Hong-Wei He, Jiaxing Wang, (unknown), Jinlong Huang, Yabing Cao, Jian Zhou, Jia Fan, Shuang‐Jian Qiu	63
16	Breast-specific gamma imaging with Tc-99m-sestamibi in the diagnosis of breast cancer and its semiquantitative index correlation with tumor biologic markers, subtypes, and clinicopathologic characteristics 2016 ·Nuclear Medicine Communications ·Hui Tan, Hongwei Zhang, Weige Yang, Yi‐Peng Fu, (unknown), Min Du, Dengfeng Cheng, Hongcheng Shi	15
17	Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection 2016 ·Medicine ·Xiaoyan Cai, Xiaochun Ni, Yong Yi, Hong-Wei He, Jiaxing Wang, Yi‐Peng Fu, Jian Sun, Jian Zhou, Yunfeng Cheng, (unknown), Jia Fan, Shuang–Jian Qiu	59
18	Serum Amyloid A is a Novel Prognostic Biomarker in Hepatocellular Carcinoma 2015 ·Asian Pacific Journal of Cancer Prevention ·Xiaochun Ni, (unknown), Yi‐Peng Fu, Hong-Wei He, Xiaoyan Cai, Jiaxing Wang, Jian Zhou, Jia Fan, Shuang–Jian Qiu	18
19	Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma 2015 ·Medicine ·Xiaochun Ni, Yong Yi, Yi‐Peng Fu, Hong-Wei He, Xiaoyan Cai, Jiaxing Wang, Jian Zhou, (unknown), Jianjun Jin, Jia Fan, Shuang–Jian Qiu	49
20	Association between cytochrome P450 2C9 gene polymorphisms and colorectal cancer susceptibility: evidence from 16 case–control studies 2014 ·Tumor Biology ·Hong Wang, Li Ren, Yifeng He, Ye Wei, Zenggan Chen, Weige Yang, Yi‐Peng Fu, Xiaoyue Xu, (unknown), (unknown), Wenhui Lou	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact